PROSPECTS FOR HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THE FIRST LINE OF THERAPY FOR AGGRESSIVE NON-HODGKIN’S LYMPHOMAS. Вопр. онкол. [Internet]. 2017 Feb. 1 [cited 2026 Oct. 14];63(2):326-8. Available from: https://voprosyonkologii.ru/index.php/journal/article/view/712